Aster DM Healthcare (ASTERDM) Fundamentals 2026 — P/E 106.2x, Revenue Analysis | SniperIQ
Aster DM Healthcare (ASTERDM) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹41,386 Crore, trading at ₹799.35 on the BSE. This SniperIQ fundamentals page covers Aster DM Healthcare's valuation (P/E 106.2x, P/B 9.0x), profitability (net margin 8.4%), revenue (₹4,643 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Aster DM Healthcare's market cap?
Aster DM Healthcare (ASTERDM) has a market capitalization of approximately ₹41,386 Crore, trading at ₹799.35 on the BSE. Market cap moves with the live share price.
What is Aster DM Healthcare's P/E ratio?
Aster DM Healthcare's trailing twelve-month P/E ratio is 106.2x, with a price-to-book (P/B) of 9.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Aster DM Healthcare?
Aster DM Healthcare runs a net profit margin of 8.4%, a gross margin of 53.8%, and an operating margin of 13.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Aster DM Healthcare generate?
Aster DM Healthcare reported revenue of ₹4,643 Crore for fiscal year 2026, with net income of ₹388 Crore and earnings per share (EPS) of 7.53. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Aster DM Healthcare pay a dividend?
Aster DM Healthcare offers a trailing dividend yield of about 0.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Aster DM Healthcare financially healthy?
Aster DM Healthcare carries a debt-to-equity ratio of 0.49x and a current ratio of 1.99x, with a market beta of -0.04. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Aster DM Healthcare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Aster DM Healthcare (ASTERDM) the key facts are: market cap ₹41,386 Crore, P/E 106.2x, revenue ₹4,643 Crore, 52-week range 519.8-847.95. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Aster DM Healthcare's full fundamentals live
Get Aster DM Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.